NCT02207530 Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT02200666 Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use Status COMPLETED Phase N/A
NCT02200627 Forxiga Tablets Specific Clinical Experience Investigation for Elderly Status COMPLETED Phase N/A
NCT02197247 Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC Status COMPLETED Phase PHASE1
NCT02197234 Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC Status COMPLETED Phase PHASE1
NCT02194699 A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma Status COMPLETED Phase PHASE3
NCT02193633 A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. Status COMPLETED Phase PHASE1
NCT02190123 REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux. Status COMPLETED Phase N/A
NCT02189252 An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis Status COMPLETED Phase PHASE1
NCT02187926 Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in Greece Status COMPLETED Phase N/A
NCT02184195 Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy Status COMPLETED Phase PHASE3
NCT02181101 Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial Status COMPLETED Phase PHASE3
NCT02180711 Study of Acalabrutinib Alone or in Combination Therapy in Subjects With B-cell Non-Hodgkin Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02179671 Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02178059 Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2 Status COMPLETED Phase PHASE1
NCT02176252 Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects Status COMPLETED Phase PHASE1